celiac and semaglutide GLP-1s Disease A Randomized Trial of a

This study investigated whether semaglutide (SMG) can counteract the disruption to the gut-heart-metabolic axis and associated myocardial injury caused by obesity

Not sure what the differences are between the weight loss treatments Mounjaro and Wegovy are?

Print or Use on Tablet

This article reviews clinical evidence, what providers consider when evaluating treatment timing, and how genetic and metabolic factors may inform pre-pregnancy planning conversations with qualif

Tackling multiple diseases with a single prescription, making GLP-1s a disruptor in todays medical landscape

It is not suitable for use during pregnancy, breastfeeding, or in people under 18 years of age